What does a fecal calprotectin level of 192 signify?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fecal Calprotectin of 192 μg/g: Interpretation and Management

What This Level Means

A fecal calprotectin of 192 μg/g falls in the intermediate range (100-250 μg/g) and indicates probable intestinal inflammation requiring further evaluation with either repeat testing or gastroenterology referral, depending on your symptom severity. 1

This level is:

  • Above the standard cutoff of 50 μg/g used to rule out inflammatory bowel disease (IBD), making IBD significantly more likely than irritable bowel syndrome (IBS) 2
  • Below the 250 μg/g threshold that strongly correlates with active endoscopic inflammation and typically requires treatment intensification 2, 3
  • In the "gray zone" where approximately 8% of patients will develop IBD over 12 months, compared to only 1% in those with levels <50 μg/g 2

Immediate Next Steps Based on Your Symptoms

If You Have Moderate to Severe Symptoms

Urgent gastroenterology referral for colonoscopy is warranted. 1 Moderate to severe symptoms include:

  • Rectal bleeding with abdominal pain 1
  • Significant weight loss 1
  • Frequent diarrhea (>6 stools daily) 1
  • Severe abdominal pain 1

At this calprotectin level with moderate-severe symptoms, there is a 95.4% probability of finding moderate to severe endoscopic inflammation. 3

If You Have Mild or Minimal Symptoms

Consider repeat calprotectin testing in 2-3 weeks to determine if the elevation is persistent or transient. 1 If the repeat test shows:

  • <100 μg/g: Treat as IBS in primary care 1
  • Persistently 100-250 μg/g: Refer to gastroenterology for routine evaluation 1
  • >250 μg/g: Urgent gastroenterology referral 1

If You Have Alarm Features

Immediate referral via suspected cancer pathway is required regardless of calprotectin level. 1 Alarm features include:

  • Rectal bleeding 1
  • Iron-deficiency anemia 1
  • Unintentional weight loss 1
  • Change in bowel habit (age >40) 1

Essential Baseline Testing Before Gastroenterology Referral

Complete these tests in primary care: 1

  • Complete blood count (assess for anemia, thrombocytosis indicating inflammation)
  • Urea and electrolytes (assess for dehydration, electrolyte abnormalities)
  • C-reactive protein (complementary inflammatory marker, though 20% of active Crohn's patients may have normal CRP)
  • Celiac screen (tissue transglutaminase antibodies to exclude celiac disease)
  • Stool culture (to exclude infectious causes of inflammation)

What Could Be Causing This Elevation

Most Likely: Inflammatory Bowel Disease

At 192 μg/g, IBD (Crohn's disease or ulcerative colitis) is the most probable diagnosis. 2, 4 The sensitivity for detecting endoscopically active IBD at the 50 μg/g cutoff is 90.6%, and your level is nearly 4 times higher. 1

Other Important Causes to Consider

Calprotectin is not specific for IBD and can be elevated in: 2, 1

  • Colorectal cancer (colonoscopy will evaluate for this)
  • Infectious gastroenteritis (stool culture will help exclude this)
  • NSAID use within the past 6 weeks (can falsely elevate levels)
  • Microscopic colitis
  • Hemorrhoids (can cause false elevation due to local bleeding and inflammation) 1

Critical Caveats

NSAID Use

If you have taken NSAIDs (ibuprofen, naproxen, aspirin) in the past 6 weeks, repeat testing after NSAID cessation is appropriate, as NSAIDs can falsely elevate calprotectin. 1

Specificity Limitations

While calprotectin at this level has moderate specificity (66%) for detecting active endoscopic inflammation, clinical judgment must override biomarkers when alarm features are present. 5, 1

Not Sensitive for Cancer

Calprotectin is not sensitive enough to exclude colorectal cancer, which is why alarm features require cancer pathway referral regardless of calprotectin result. 1

What to Expect at Gastroenterology

The gold standard evaluation will likely include: 1

  • Ileocolonoscopy with biopsies to diagnose IBD, assess disease extent and severity, and differentiate Crohn's disease from ulcerative colitis
  • Cross-sectional imaging (MRI or CT enterography) may be needed to assess small bowel involvement and complications such as strictures, fistulas, or abscesses

Bottom Line

Your calprotectin of 192 μg/g indicates probable intestinal inflammation that requires further investigation. The urgency depends on your symptom severity: urgent referral for moderate-severe symptoms, repeat testing or routine referral for mild symptoms, and immediate cancer pathway referral for any alarm features. 3, 1 Complete the baseline blood and stool tests while awaiting gastroenterology evaluation, and avoid NSAIDs if possible. 1

References

Guideline

Calprotectin as a Biomarker for Intestinal Inflammation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fecal Calprotectin Guidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009

Guideline

Fecal Calprotectin in Inflammatory Bowel Disease Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.